S-1/A: Buda Juice Files for IPO, Targets National UltraFresh Expansion

Buda Juice, a pioneer in the UltraFreshTM juice category, files for an IPO to raise up to $20 million, targeting NYSE listing and funding national expansion and a CEO stock redemption.

Summary

• Buda Juice, LLC is converting to Buda Juice, Inc. and plans an Initial Public Offering (IPO) of 2,666,667 shares of common stock, with an estimated price range of $7.50 to $9.00 per share.
• The company aims to raise approximately $18.08 million in net proceeds (or $20.87 million if the over-allotment option is fully exercised) to fund the development of new production plants in South Carolina (2026) and Arizona/Nevada (2027), expand its existing Texas plant, and redeem 500,000 shares from CEO Horatio Lonsdale-Hands for $3.75 million.
• Buda Juice reported net sales growth from $5.6 million in 2022 to $11.2 million in 2024, representing a 41.8% Compound Annual Growth Rate (CAGR).
• For the nine months ended September 30, 2025, net sales increased by 14.3% to $9.714 million, and net income increased by 9.5% to $2.858 million.
• The company's business model focuses on pioneering the 'UltraFreshTM' juice category, offering cold-crafted, never heat-treated, never HPP-processed, and always cold citrus-based beverages with an 8-12 day shelf life.
• A significant customer concentration exists, with one customer accounting for approximately 97% of net sales for the six months ended June 30, 2025, and 95% and 90% for the years ended December 31, 2024, and 2023, respectively.
• The company will list its common stock on the New York Stock Exchange (NYSE) under the symbol BUDA, contingent upon approval.

Sentiment

Score: 7

Explanation: The company demonstrates strong historical financial growth and a clear strategy for national expansion in an underserved market segment. The 'UltraFreshTM' positioning offers a compelling competitive advantage. However, the very high customer concentration and the use of a significant portion of IPO proceeds for CEO stock redemption introduce notable risks that temper the overall positive outlook.

Positives

• Demonstrated strong revenue growth, with net sales increasing from $5.6 million in 2022 to $11.2 million in 2024 (41.8% CAGR), and a 14.3% increase to $9.714 million for the nine months ended September 30, 2025.
• Achieved consistent profitability, with net income of $3.574 million in 2024 (32% margin) and $2.858 million for the nine months ended September 30, 2025 (30% margin).
• Maintained healthy gross margins, reaching 46% in 2024 and 45.4% for the nine months ended September 30, 2025, indicating efficient cost management.
• Pioneering the 'UltraFreshTM' juice category with a unique cold-chain platform that delivers superior taste, nutritional integrity, and food safety without heat treatment or HPP.
• Executing a disciplined geographic expansion strategy with planned facilities in South Carolina (2026) and Arizona/Nevada (2027) to serve a large percentage of the U.S. population.
• Leverages an asset-light supply chain model and long-term relationships with citrus growers, ensuring consistent premium fruit supply and competitive pricing.
• The executive team brings decades of experience and established relationships with major U.S. grocery retailers, facilitating distribution expansion.

Negatives

• High customer concentration, with one customer accounting for approximately 97% of net sales for the six months ended June 30, 2025, posing a significant risk if this relationship is disrupted.
• Limited operating history in new and evolving markets, making it difficult to evaluate future prospects and plan for growth outside its current Texas region.
• Operates in a highly competitive beverage industry with larger, better-capitalized competitors who have more established brand recognition and distribution capabilities.
• Reliance on a limited number of cold chain-dependent production and distribution facilities, making operations vulnerable to disruptions from mechanical failure, labor shortages, or natural disasters.
• Business model depends on maintaining strict cold chain logistics from sourcing through delivery, adding operational complexity, cost, and vulnerability to temperature excursions or logistical delays.
• Products have a short shelf life, increasing exposure to inventory spoilage, write-downs, and stockouts if demand forecasting or logistics are not perfectly managed.
• A significant portion of IPO proceeds ($3.75 million) will be used to redeem shares from the CEO, reducing capital available for direct business expansion.

Risks

• Limited operating history in new and evolving markets, making future prospects difficult to evaluate.
• Historical financial and operating results may not be indicative of future performance, and profitability may not be sustained.
• Highly competitive beverage industry with larger and better-capitalized competitors.
• Success depends on the continued strength of the brand and consumer perception of product quality, safety, freshness, and healthfulness.
• Future growth depends on the successful development and acceptance of new products and product innovation.
• Reliance on a limited number of cold chain-dependent production and distribution facilities, vulnerable to disruptions.
• Business model depends on maintaining strict cold chain logistics, adding complexity, cost, and vulnerability.
• Dependence on the availability, cost, and quality of fresh citrus and other raw ingredients, subject to agricultural or climate-related disruptions.
• Production facilities must maintain compliance with rigorous food safety and regulatory standards; any lapse could result in recalls, liability, or reputational harm.
• Risks associated with managing short shelf-life products, increasing exposure to inventory spoilage, write-downs, and stockouts.
• Changes in consumer preferences, particularly away from fresh juice, citrus beverages, or premium-priced fresh products, could adversely affect demand.
• Growth strategy depends on geographic expansion, which requires securing and equipping new facilities and may be costly and complex.
• High reliance on a single customer (97% of net sales for 9 months ended Sept 30, 2025); loss or reduction in purchases would materially affect the business.
• Dependence on a limited number of suppliers for products; loss of one or more could disrupt operations or increase costs.
• Growth depends on expanding distribution through new retail relationships and deeper penetration with existing accounts; failure to secure or maintain these relationships may limit revenue potential.
• Heavy dependence on third-party retailers and brokers to market and sell products; their execution or financial health may directly impact performance.
• High-tech driven, centralized production systems are core to efficiency and quality; technical failures or cybersecurity incidents could disrupt operations or result in data loss.
• Reliance on third-party logistics providers for delivery; any breakdown or delay could damage product integrity and customer trust.
• Difficulties in forecasting demand accurately could lead to excess inventory, underproduction, missed revenue opportunities, or higher working capital needs.
• Failure to effectively manage growth, including geographic expansion and increased retail distribution, could harm operations and customer experience.
• Potential legal challenges related to the accuracy of health and wellness claims.
• Future success depends on the ability to attract, retain, and develop key employees and senior leadership.
• May require additional capital to support growth strategy or operations, and financing may not be available on acceptable terms or at all.
• Disruptions in the worldwide economy may adversely affect business, financial condition, results of operations, and cash flows.
• Climate change, or legal/market measures to address it, may negatively affect business and operations.
• Fluctuations in business conditions may unexpectedly impact reported results of operations and financial condition.
• Insurance may not provide adequate levels of coverage or may be unavailable at reasonable cost.
• Management team has limited experience operating a public company, and regulatory compliance may divert attention.
• Increased costs as a result of operating as a public company, requiring substantial management time for compliance.
• No prior public market for common stock; an active market may not develop or be sustainable.
• Price of common stock may be volatile, leading to substantial losses for purchasers.
• A portion of IPO proceeds will redeem shares from the CEO, reducing funds for company expansion.
• Substantial portion of total issued and outstanding shares may be sold into the market at any time, potentially causing stock price to drop.
• If NYSE listing application is not approved, the offering will be terminated.
• Authorization to issue blank check preferred stock without stockholder approval could adversely impact common stockholders' rights.
• If shares become subject to penny stock rules, it would be more difficult to trade.
• As an emerging growth company, reduced reporting requirements may make stock less attractive to some investors.
• Broad discretion in the use of net proceeds from the offering, which may not be used effectively.
• No intention to pay dividends on common stock; return on investment depends on stock price appreciation.
• No independent valuation of stock, meaning it may be worth less than the offering price.
• If securities industry analysts do not publish research reports or publish unfavorable ones, market price and trading volume could be negatively affected.
• Future issuances of debt or equity securities ranking senior to common stock may adversely affect return.
• Delaware law and provisions in certificate of incorporation and bylaws could make a merger, tender offer, or proxy contest more difficult, limit attempts to replace management, and depress market price.

Future Outlook

Buda Juice plans a disciplined, infrastructure-led geographic expansion strategy with new production facilities in South Carolina (projected 2026) and Arizona/Nevada (projected 2027) to serve a large percentage of the U.S. population. The company intends to implement a multi-channel sales approach, including regional and national broker networks, and increase marketing investment to build brand awareness and drive consumer purchasing, particularly for its branded products. Channel expansion beyond grocery retail into restaurants, bars, hotels, and institutional food service is also planned.

Management Comments

• Horatio Lonsdale-Hands, Co-Founder and CEO: 'At Buda Juice, we started small—one RAW.ORGANIC.REAL. sip at a time. As life became busier, convenience often meant sacrificing health. Recognizing this challenge, we set out to offer delicious, genuinely fresh juices, making it effortless for people to incorporate more fruits and vegetables into their daily lives.'
• Horatio Lonsdale-Hands: 'Buda Juice is pioneering a new category in beverages, UltraFreshTM juice, offering cold-crafted citrus-based drinks that are never heat-treated, never HPP-processed and always cold.'
• Horatio Lonsdale-Hands: 'Looking ahead, we believe our opportunity is brilliant. We are not simply capturing market share—we believe we are expanding the refrigerated juice category itself by helping retailers evolve to the next generation of freshness.'
• Management believes the company's operating cash flow, access to credit facilities, and the IPO will provide sufficient capability to support growth plans.
• Management states that the company has 'always been focused on production safety first, profitable, responsible, and sustainable growth.'

Industry Context

The U.S. fruit juice market is substantial, valued at $55.5 billion in 2024 and projected to reach $77.5 billion by 2033, growing at a 3.8% CAGR. Supermarkets and hypermarkets account for 60-70% of total juice sales, aligning with Buda Juice's retail-focused model. The global lemonade segment shows significant momentum, valued at $9.7 billion in 2024 and projected to reach $16.7 billion by 2034 (6.3% CAGR), with the U.S. representing about 27% of this market. Nearly two-thirds of Americans consume juice weekly, with Gen Z and Millennials prioritizing health, freshness, convenience, and flavor. The freshly squeezed juice category remains underpenetrated, with no competitors achieving significant scale, creating a substantial opportunity for Buda Juice's centralized UltraFreshTM model.

Comparison to Industry Standards

• Buda Juice differentiates itself from traditional heat-processed juice brands like Tropicana (PepsiCo), Minute Maid, and Simply Orange (Coca-Cola), which extend shelf life to 60 days-12 months but degrade flavor and nutrients. Buda Juice's UltraFreshTM process maintains an 8-12 day shelf life with uncompromised flavor and nutritional integrity.
• The company contrasts its products with High-Pressure Processing (HPP) brands such as Suja Juice, Naked, Evolution Fresh, and Bolthouse Farms. While HPP extends shelf life to 30-90 days and maintains better nutritional content than heat processing, Buda Juice claims HPP still alters molecular structure and cannot achieve true fresh taste.
• Buda Juice's centralized production model addresses the operational complexities and high costs associated with boutique cold-pressed juice bars (3-5 day shelf life) and in-store fresh-squeezed juice operations (less than 5% of U.S. grocery stores have this capability), which require significant capital investment, dedicated clean spaces, specialized equipment, and trained labor.
• The company's continuous 35F cold chain system from fruit to shelf is a key differentiator, ensuring food safety and quality by slowing bacterial growth and preserving nutrients and flavor, unlike competitors relying on pasteurization or HPP.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not currently a party to any material legal proceedings.
• Approximately six years ago, the company encountered a third-party opposition from a kombucha company using the name Buddha during its trademark application process in Canada. The application was abandoned as Canadian trademark registration was not deemed necessary for U.S. market development strategy.

Related Party Transactions

• The company's revolving line of credit with Amegy Bank, which was renewed on July 9, 2025, and had no outstanding balance as of September 30, 2025, is supported by personal guarantees from three members of the Board of Directors: Horatio Lonsdale-Hands (CEO), Bryan Herr (Executive Chairman), and Bernard Lucien Nussbaumer (Co-Founder and Director).
• A portion of the IPO proceeds, specifically $3,750,000, will be used to redeem 500,000 shares of Common Stock held by Horatio Lonsdale-Hands, one of the co-founders and the Chief Executive Officer.
• Karina Farquharson, Vice President of Marketing & Data Analytics, is the wife of the CEO, Horatio Lonsdale-Hands.

Stakeholder Impact

• **Shareholders**: New investors will experience immediate and substantial dilution of $5.92 per share due to the IPO price being significantly higher than the pro forma net tangible book value. Existing shareholders, particularly the co-founders, will retain significant influence over corporate matters (60.77% beneficial ownership post-IPO for Horatio Lonsdale-Hands, Bryan Herr, and Bernard Lucien Nussbaumer).
• **Employees**: The adoption of the 2025 Incentive Award Plan with a 15% option pool aims to attract, motivate, and retain key personnel, aligning their interests with the company's long-term success. However, the competitive labor market for specialized talent remains a challenge.
• **Customers (Retailers)**: The company's 'UltraFreshTM' model offers a turnkey solution, eliminating the need for retailers to invest in in-store juicing infrastructure, potentially increasing their fresh juice offerings. However, the high customer concentration (97% from one customer) poses a risk to the company's stability if that relationship changes, which could indirectly impact other customers.
• **Suppliers**: The company maintains long-term relationships with citrus growers and relies on a limited number of suppliers. While diversification efforts are noted, disruptions in supply or price increases could impact the company's ability to meet demand and maintain margins, potentially affecting supplier relationships.
• **Creditors**: The company has repaid its line of credit and has no outstanding debt as of September 30, 2025, improving its credit profile. However, the line of credit is still supported by personal guarantees from key directors, indicating continued personal financial exposure for these individuals.

Next Steps

• Consummate the statutory conversion from Buda Juice, LLC to Buda Juice, Inc. immediately before the closing of the IPO.
• List common stock on the New York Stock Exchange (NYSE) under the symbol BUDA.
• Develop and furnish a new production plant in South Carolina (Phase Two) by 2026.
• Develop and furnish a new production facility in Arizona/Nevada (Phase Three) by 2027.
• Expand the existing Dallas plant with continuing capital expenditure initiatives.
• Redeem 500,000 shares of Common Stock from CEO Horatio Lonsdale-Hands for $3.75 million upon closing of the IPO.
• Adopt the 2025 Incentive Award Plan upon NYSE listing, subject to stockholder approval, with a 15% option pool for employees and executives.
• Enter into separate indemnification agreements with each director and executive officer prior to IPO consummation.
• Adopt a written related person transaction policy, code of business conduct and ethics, and a clawback policy prior to IPO consummation.
• Form an audit committee, compensation committee, and nominating and corporate governance committee with independent directors.

Key Dates

Recommendation

Buda Juice presents a compelling growth story in the underserved 'UltraFreshTM' juice category, backed by strong historical revenue and profit growth, innovative cold-chain technology, and a clear national expansion strategy. The company's ability to differentiate itself from traditional and HPP competitors is a significant positive. However, the extremely high customer concentration (97% from one customer) introduces a substantial single-point-of-failure risk that cannot be overlooked. While diversification efforts are underway, their impact is not yet material. The use of a portion of IPO proceeds for CEO stock redemption, while disclosed, may also be viewed critically by some investors. Given the strong potential but also the significant concentration risk, a 'hold' recommendation is appropriate for seasoned investors, suggesting monitoring the progress of customer diversification and geographic expansion before making a more aggressive investment decision.

Keywords

UltraFresh Juice, Cold-Crafted Beverages, SEC S-1/A Filing, Initial Public Offering, IPO, Buda Juice, Beverage Industry, Food and Beverage, Retail Distribution, Cold Chain Logistics, Corporate Conversion, NYSE Listing, Food Safety, SQF Certified, Juice HACCP, Geographic Expansion, Private Label, Wellness Shots, Citrus Juices